{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
CytoSorbents Corp.
Who are in the management team of CytoSorbents Corp.?
As of March 2022, the management team of CytoSorbents Corp. includes Al Kraus (Independent Non-Executive Chairman), Phillip Chan (President and CEO), and independent directors Michael Bator, Edward Jones, and Alan Sobel. This team provides governance and strategic direction for the company.
What does CytoSorbents Corp. do?
CytoSorbents Corporation is a micro-cap immunotherapy company specializing in blood purification technology, specifically its product CytoSorb. As of March 2025, it reported net sales of $9 million and a market cap of $75.13 million.
How big is CytoSorbents Corp.?
As of Jun 18, CytoSorbents Corp. has a market capitalization of 75.13 million, with net sales of 34.53 million and a net profit of -15.83 million over the last four quarters. The company's shareholder's funds are 11.11 million, and total assets amount to 50.96 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
